Acura Pharmaceuticals Inc (ACUR)
0.0017
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Acura Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.8427 |
| September 30, 2021 | 1.970 |
| June 30, 2021 | 1.400 |
| March 31, 2021 | -1.065 |
| December 31, 2020 | -1.064 |
| September 30, 2020 | -1.108 |
| June 30, 2020 | -1.257 |
| March 31, 2020 | -1.131 |
| December 31, 2019 | -1.266 |
| September 30, 2019 | -1.220 |
| June 30, 2019 | -1.166 |
| March 31, 2019 | -1.066 |
| December 31, 2018 | -1.168 |
| September 30, 2018 | -0.8534 |
| June 30, 2018 | -1.117 |
| March 31, 2018 | -1.564 |
| December 31, 2017 | -99.78 |
| September 30, 2017 | 2.262 |
| June 30, 2017 | -13.40 |
| March 31, 2017 | 2.884 |
| December 31, 2016 | 4.527 |
| September 30, 2016 | -12.66 |
| June 30, 2016 | 4.150 |
| March 31, 2016 | 1.553 |
| December 31, 2015 | 0.981 |
| Date | Value |
|---|---|
| September 30, 2015 | 0.9751 |
| June 30, 2015 | 2.159 |
| March 31, 2015 | 1.491 |
| December 31, 2014 | 1.892 |
| September 30, 2014 | 1.278 |
| June 30, 2014 | 0.9379 |
| March 31, 2014 | 0.7111 |
| December 31, 2013 | 0.5356 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.266
Minimum
Dec 2019
1.970
Maximum
Sep 2021
-0.2975
Average
-1.065
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.406M |
| Total Liabilities (Quarterly) | 1.271M |
| Shareholders Equity (Quarterly) | 0.135M |